BioNTech SE (BNTX) Return on Capital Employed (2019 - 2025)
BioNTech SE (BNTX) posted Return on Capital Employed of 6.85% for Q4 2025, down 47.77% on a QoQ basis from 4.63% in Q3 2025, and down 28.0% year-over-year from 9.51% in Q4 2024.
BioNTech SE (BNTX) has 7 years of Return on Capital Employed data on file, last reported at 6.85% in Q4 2025.
- In Q4 2025, Return on Capital Employed fell 28.0% year-over-year to 6.85%; the TTM figure through Dec 2025 stood at 6.85% (down 28.0% YoY), while the FY2025 annual figure was 7.2%, down 74.0% from the prior year.
- Return on Capital Employed declined to 6.85% in Q4 2025, from 4.63% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 12460520.5% in Q1 2021 and bottomed at 6.85% in Q4 2025.
- A 5-year average of 1146096.06% and a median of 21.27% in 2023 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 1246054706 bps in 2021, down 1933158521 bps in 2021.
- Year by year, Return on Capital Employed stood at 133.74% in 2021, then slumped by 50 bps to 66.34% in 2022, then slumped by 95 bps to 3.3% in 2023, then tumbled by 299 bps to 6.57% in 2024, then fell by 4 bps to 6.85% in 2025.
- The last three Return on Capital Employed figures came in at 6.85% (Q4 2025), 4.63% (Q3 2025), and 4.5% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -6.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.85% |
| Sep 30, 2025 | -4.63% |
| Jun 30, 2025 | -4.50% |
| Mar 31, 2025 | -6.64% |
| Dec 31, 2024 | -6.57% |
| Sep 30, 2024 | -4.71% |
| Jun 30, 2024 | -4.41% |
| Mar 31, 2024 | -2.28% |
| Dec 31, 2023 | 3.30% |
| Sep 30, 2023 | 15.88% |
| Jun 30, 2023 | 26.65% |
| Mar 31, 2023 | 40.01% |
| Dec 31, 2022 | 66.34% |
| Sep 30, 2022 | 82.67% |
| Jun 30, 2022 | 100.79% |
| Mar 31, 2022 | 132.36% |
| Dec 31, 2021 | 133.74% |
| Sep 30, 2021 | 3,586,096.75% |
| Jun 30, 2021 | 6,874,742.72% |
| Mar 31, 2021 | 12,460,520.50% |
| Dec 31, 2020 | 19,331,718.96% |
| Sep 30, 2020 | 2.72% |
| Jun 30, 2020 | -20.78% |
| Mar 31, 2020 | -26.56% |
| Dec 31, 2019 | -28.39% |